MFB holds 3c dividend at 150% of NPAT as PBT falls 36% and OCF halves

What changed

Revenue fell 4.1% to $94.4m and gross margin improved 120bps to 49.3%, but every line below that moved the wrong way. EBITDA declined 28.1% to $11.5m, PBT fell 36.2% to $8.2m and NPAT fell 37.7% to $5.9m. Operating cash flow more than halved, down 56.1% to $5.5m, while capex jumped to $2.8m from $0.4m. Cash on the balance sheet was effectively drained, falling to $0.1m from $1.8m, and gross borrowings rose to $6.0m, lifting net debt to $5.9m from $4.0m. The 3.0 cent interim dividend was held flat.

What matters

• Margin gain did not reach the P&L. Gross margin expanded 120bps yet EBITDA fell 28% on a 4% revenue decline, indicating meaningful operating deleverage through fixed-cost lines below gross profit. The gap between the gross margin story and the earnings outcome is the central read.
• Cash conversion deteriorated materially. OCF/EBITDA fell to 47.7% from 78.1%. Combined with capex rising nearly eightfold to $2.8m (2.98% of revenue vs 0.38%), pre-lease free cash flow collapsed to $2.7m from $12.1m. FCF covered only 45% of NPAT versus 128% a year ago.
• Dividend is no longer covered by earnings. At an unchanged 3.0 cents, the interim payout is running at approximately 150% of NPAT for the half, up from roughly 75% in HY22. With cash at $0.1m and net debt/EBITDA rising to 0.51x from 0.25x, the dividend is now being funded from the balance sheet rather than the period's earnings.

Expectations

No forward targets or guidance are disclosed in the release. Using HY22 seasonality as a shape guide, HY revenue represented 50.8% of FY22 revenue, so the half does not carry an obvious second-half recovery tailwind baked into the comparison. Annualising HY23 revenue gives roughly $188.8m, about 2.7% below FY22's record $194.0m, implying the current run-rate is softer than the prior full year rather than tracking to a new high. The release does not support any claim of an imminent H2 reacceleration; it documents cost pressure and a weaker cash run-rate.

Quality of result

The quality is poor. The only clearly durable positive is the 120bps gross margin improvement. Against that, the earnings decline is operational (PBT down 36.2%, NPAT down 37.7%, with only a 1.5pp tax-driven gap between them — no discontinued operation or unusual tax item is doing the work). Operating cash flow fell materially faster than EBITDA, pointing to working-capital drag rather than a timing benefit. Inventory days rose to 5.4 from 4.8. Capex has stepped up from a depressed base and is no longer negligible. The period is not flattered by disposals, one-offs, or tax; it is a clean, weak operating read.

Unresolved

• What drove the sharp OCF decline beyond the EBITDA fall — is it inventory build, payables normalisation, or something else not visible in the extracted working-capital lines?
• Is the capex step-up ($2.8m including $1.3m software development) a sustained investment level or a one-half catch-up?
• Can the 3.0 cent dividend be maintained through H2 if earnings and cash generation remain under pressure, given the $0.1m cash balance and rising net debt?
• No EBITDA-to-statutory profit bridge is provided for the non-GAAP measure, and no FY23 target or forward-work metric is disclosed.

This briefing cannot assess customer/active-subscriber trends, cost-line detail below gross margin, or management's forward view, none of which are present in the supplied excerpts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.